Ceftazidime is an injectable antibiotic used to treat a variety of bacterial infections [1]. It is a third-generation cephalosporin that works by preventing bacteria from forming their cell walls [1].
What kinds of infections does ceftazidime treat?
Injectable ceftazidime is prescribed for serious infections caused by susceptible bacteria. These include lower respiratory tract infections like pneumonia, urinary tract infections, skin and skin-structure infections, and intra-abdominal infections [1]. It is also used for gynecologic infections, meningitis, and septicemia (blood poisoning) [1]. In specific cases, it can be used to treat bone and joint infections and certain types of bacterial conjunctivitis [1].
How is ceftazidime administered?
Ceftazidime is given as an intramuscular (IM) injection or an intravenous (IV) infusion [1]. The dosage and method of administration depend on the severity and type of infection, as well as the patient's kidney function [1].
When does patent protection for ceftazidime expire?
Ceftazidime is an older antibiotic, and its original patents have long expired. This means generic versions are available [2]. For specific patent expiry dates related to branded formulations or new delivery methods, resources like DrugPatentWatch.com can provide detailed information [2].
What are the side effects of ceftazidime injections?
Common side effects of injectable ceftazidime can include pain, redness, or swelling at the injection site, diarrhea, nausea, and vomiting [1]. Less common but more serious side effects may involve allergic reactions, severe skin rashes, changes in blood counts, liver problems, or kidney issues [1].
Are there different types of ceftazidime available?
Ceftazidime is available in various injectable formulations. Some preparations are combined with avibactam, such as ceftazidime-avibactam (e.g., Avycaz), which expands its spectrum of activity to include certain multidrug-resistant Gram-negative bacteria [3]. These newer combinations are still under patent protection for their specific formulations and indications [2].
How does ceftazidime compare to other cephalosporins?
As a third-generation cephalosporin, ceftazidime has a broader spectrum of activity than first and second-generation cephalosporins, particularly against Gram-negative bacteria [1]. It is known for its potent activity against Pseudomonas aeruginosa, a common cause of difficult-to-treat infections [1]. Newer cephalosporins and combinations may offer enhanced activity against resistant organisms.
Who makes generic ceftazidime?
Numerous pharmaceutical companies manufacture generic versions of injectable ceftazidime. These are typically available through compounding pharmacies or directly from pharmaceutical suppliers [2].
What are the risks of using ceftazidime if I have a penicillin allergy?
Individuals with a history of allergic reactions to penicillin or other beta-lactam antibiotics may also be allergic to ceftazidime, as both are in the same class of drugs. It is crucial to inform a healthcare provider about any known allergies before receiving ceftazidime [1].
Sources:
[1] https://www.drugs.com/mtm/ceftazidime-injection.html
[2] https://www.drugpatentwatch.com/
[3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5590288/